There are currently more than 150 different COVID-19 vaccines under development. Of these, more than 50 have reached human trials, and seven have been approved for emergency or full use in parts of Europe, North America, and Asia. In the United States, two vaccines—one from the biotechnology company, Moderna and the other from drug giant Pfizer—have been granted an Emergency Use Authorization (EUA) from the FDA. To read the full story.
Recent Posts
- Meet the policy shop dedicated to a healthier New Jersey
- How the FDA Opens the Door to Risky Chemicals in America’s Food Supply
- Amid Trump’s ire, can Harvard afford to lose federal research funds?
- Most residents don’t know N.J. offers medical aid in dying, survey finds.
- Rutgers Researchers Revive Decades-Old Pregnancy Cohort with Modern Scientific Potential.
Categories
- Community (2,221)
- Covid (985)
- CTO Events (6)
- News (2,832)
- Pilots (21)